Baseline characteristics and adverse effects on day 2 of ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccination (first dose) in ESRD patients on hemodialysis (N = 270).
收藏NIAID Data Ecosystem2026-03-13 收录
数据链接：
官方服务：
资源简介：
Baseline characteristics and adverse effects on day 2 of ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccination (first dose) in ESRD patients on hemodialysis (N = 270).
创建时间：
2022-09-09
